Pharma Journalist 9027 posts 0 comments

Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced on May 26th that it had acquired a 50% stake in RosVivo Therapeutics Inc. ("Rosvivo"), an American new drug…
Read More...

AnHeart Therapeutics Co., Ltd. a clinical stage oncology company focused on underserved patients in global markets, and Innovent Biologics, Inc. an innovative leading biopharmaceutical…
Read More...

SMi Reports: Registration is now open for the 2nd Annual Next Generation Pharmaceutical Cleanroom Conference will convene in London on 6th and 7th October 2021 Following on from the…
Read More...

Samsung Biologics announced its plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility in Songdo, ready for cGMP operations within the earlier…
Read More...

SMi Group Reports: Key updates released ahead of SMi’s 4th Annual Pharmaceutical Microbiology West Coast Conference, convening in just three weeks. SMi Group are delighted to…
Read More...

Antengene Corporation Limited announced the dosing of the first patient in China in a Phase I/II trial (the HATCH trial) of eltanexor (ATG-016), a next-generation selective inhibitor of…
Read More...

AstraZeneca’s Tagrisso (osimertinib) has been approved in the European Union (EU) for the adjuvant treatment of adult patients with early-stage (IB, II and IIIA) epidermal growth factor…
Read More...

Novartis and Molecular Partners announced the start of the clinical trial EMPATHY, a Phase 2 and 3 study, to explore the use of its novel DARPin therapeutic candidate ensovibep (MP0420)…
Read More...

Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced the launch of the new highly automated DEPArray PLUS, now available with 9 fluorescent…
Read More...

Seelos Therapeutics, Inc. announced it has received European Orphan Drug Designation for SLS-005 in amyotrophic lateral sclerosis (ALS) from the European Medicines Agency (EMA)…
Read More...